Quick Answer
Bioventus Inc. reported Gross Profit of $388.16 million for fiscal year 2025.
Bioventus Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $388.16M | -0.0% |
| 2024 | $388.23M | +18.3% |
| 2023 | $328.19M | -0.9% |
| 2022 | $331.08M | +9.4% |
| 2021 | $302.71M | +29.6% |
| 2020 | $233.52M | -6.3% |
| 2019 | $249.21M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $94.23M | +0.7% | -7.7% |
| June 30, 2025 | $102.09M | -1.5% | +22.9% |
| March 31, 2025 | $83.06M | -6.0% | -11.2% |
| September 30, 2024 | $93.55M | +18.6% | -9.7% |
| June 30, 2024 | $103.64M | +16.3% | +17.3% |
| March 31, 2024 | $88.38M | +19.6% | +12.1% |
| September 30, 2023 | $78.85M | -6.7% | -11.5% |
| June 30, 2023 | $89.12M | -7.8% | +20.6% |
- Bioventus Inc. showed a decrease of -0.0% in Gross Profit compared to the prior fiscal year.
- Over the 2019–2025 period, Bioventus Inc.’s gross profit has grown by 55.8% (from $249.21 million to $388.16 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: